Affimed Announces Third Quarter 2016 Financial Results and Corporate Update Conference Call
October 26 2016 - 5:00AM
Affimed N.V. (Nasdaq:AFMD) today announced that on November 2,
2016, the Company will release its financial results for the
quarter ended September 30, 2016. The Company’s management team
will host a conference call to discuss the Company’s financial
results and recent corporate developments on Wednesday, November 2,
2016 at 8:30 a.m. ET. The call can be accessed by dialing one of
the numbers listed below five minutes prior to the start of the
call and providing the confirmation code 7663835.
|
|
Local - Amsterdam, the Netherlands: |
+31 (0) 20 716 8256 |
Local - Copenhagen, Denmark: |
+4532 71 16 59 |
Local – Frankfurt, Germany: |
+49 (0) 69 2222 10630 |
Local - Geneva, Switzerland: |
+41 (0) 22 417 7109 |
Local - London, U.K.: |
+44 (0) 20 3140 8286 |
Local - New York City, U.S.A.: |
+1 646 254 3362 |
Local - Paris, France: |
+33 (0) 1 76 77 22 22 |
|
|
An audio webcast of the conference call can be
accessed in the “Events” section on the “Media” page of the Affimed
website at http://www.affimed.com/events.php. A replay of the
webcast will be available on Affimed’s website shortly after the
conclusion of the call and will be archived on the Affimed website
for 30 days following the call.
About Affimed
Affimed (Nasdaq:AFMD) engineers targeted
immunotherapies, seeking to cure patients by harnessing the power
of innate and adaptive immunity (NK- and T-cells). We are
developing single and combination therapies to treat cancers and
other life-threatening diseases. For more information, please visit
www.affimed.com.
IR Contact:
Caroline Stewart, Head IR
Phone: +1 347394 6793
E-Mail: IR@affimed.com or c.stewart@affimed.com
Media Contact:
Anca Alexandru, Head of Communications, EU IR
Phone: +49 6221 64793341
E-Mail: a.alexandru@affimed.com
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Sep 2023 to Sep 2024